Sirolimus Therapy Predisposes to New-Onset Diabetes Mellitus After Renal Transplantation: A Long-Term Analysis of Various Treatment Regimens
- 1 June 2011
- journal article
- Published by Elsevier BV in Transplantation Proceedings
- Vol. 43 (5), 1583-1592
- https://doi.org/10.1016/j.transproceed.2011.05.001
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Impact of metabolic abnormalities for beta cell function: Clinical significance and underlying mechanismsMolecular and Cellular Endocrinology, 2009
- Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant RecipientsJournal of the American Society of Nephrology, 2008
- Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus TacrolimusAmerican Journal of Transplantation, 2007
- Transplant-Associated HyperglycemiaClinical Journal of the American Society of Nephrology, 2007
- Risk Factors for Development of New-Onset Diabetes Mellitus After Kidney TransplantationTransplantation, 2006
- Steroid Sparing in Kidney TransplantationClinical Journal of the American Society of Nephrology, 2006
- Tacrolimus and Sirolimus Cause Insulin Resistance in Normal Sprague Dawley RatsTransplantation, 2006
- Chronic Inhibition of Mammalian Target of Rapamycin Signaling Downregulates Insulin Receptor Substrates 1 and 2 and AKT ActivationJournal of the American Society of Nephrology, 2006
- Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Receiving Calcineurin or mTOR Inhibitor DrugsTransplantation, 2006
- Upstream and downstream of mTORGenes & Development, 2004